UPDATE: Thanks to all who contributed to our travel fund to send our colleague Carey Gillam to Bonn, Germany, to attend the Bayer shareholder meeting April 28. We reached our fundraising goal in five days with more than two-dozen donors including a generous contribution of frequent flier miles. Stay tuned for Carey’s reporting from Bonn.
Our colleague Carey Gillam, research director of U.S. Right to Know, has been offered a speaking slot by a Bayer shareholder’s group at the company’s upcoming annual meeting in Bonn, Germany. The April 28 meeting is expected to be widely covered by global media and will be watched closely by investors, policy makers and other corporate leaders.
Can you help us get Carey to Bonn? U.S. Right to Know is making a special funding request to cover transportation and lodging for this unexpected trip that we don’t have in our budget. If you can contribute, any amount helps. You can make a tax-deductible donation here: usrtk.org/donate
And please send us your thoughts on what we should tell Bayer! You can email Carey directly at carey@usrighttoknow.wpenginepowered.com or post comments on Facebook here.
Sign up for our newsletter to receive breaking news from the U.S. Right to Know investigations.
Follow Carey’s reporting on the Roundup litigation in the Monsanto Roundup Trial Tracker.
